header
Image from OpenLibrary

Detection of HCV in peripheral blood mononuclear cells of serum HCV negative patients under interferon treatment / Ahmed Mohammed Allam ; Supervised Manal Michel Wilson , Rania Ahmed Zayed

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Ahmed Mohammed Allam , 2010Description: 111 P. : charts ; 25cmOther title:
  • البحث عن فيروس الالتهاب الكبدي الوبائي سى فى خلايا الدم أحادية النواة للمرضى المعالجين بعقار الانترفيرون [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology Summary: Infection with hepatitis C virus (HCV) is a leading cause of chronic liver disease worldwide. Egypt has the highest prevalence of HCV with more than 90% of infections due to genotype 4. Despite recent success after the introduction of combination therapy with IFN-Ü and ribavirin, about 60% of patients with HCV genotype 4 fail to respond
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.07.M.Sc.2010.Ah.D (Browse shelf(Opens below)) Not for loan 01010110053328000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.07.M.Sc.2010.Ah.D (Browse shelf(Opens below)) 53328.CD Not for loan 01020110053328000

Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology

Infection with hepatitis C virus (HCV) is a leading cause of chronic liver disease worldwide. Egypt has the highest prevalence of HCV with more than 90% of infections due to genotype 4. Despite recent success after the introduction of combination therapy with IFN-Ü and ribavirin, about 60% of patients with HCV genotype 4 fail to respond

Issued also as CD

There are no comments on this title.

to post a comment.